Relay Pro Research
A Prospective, Multicenter, Non-Blinded, Non-Randomized Study of the RelayPro Thoracic Stent-Graft in Subjects with an Acute, Complicated Type B Aortic Dissection
About
Protocol Description
Aortic dissection is a potentially life-threatening medical condition that results from a tear in the lining of the aorta, causing bleeding between the inner and outer layers of the aortic wall, resulting in a false channel for blood flow. Aortic dissection has traditionally been managed by antihypertensive therapy or open surgery, which are both associated with high mortality rates. The objective of this study is to investigate the safety and effectiveness of the RelayPro Thoracic Stent-Graft. This study is intended to include patients with an acute, complicated type B aortic dissection.
Eligibility Criteria
Inclusion Criteria
- Patients with acute, complicated type B aortic dissection eligible for treatment with the RelayPro Thoracic Stent-Graft.
Primary Investigator
Dr. Esmaeel Reza Dadashzadeh is a dual board-certified vascular surgeon with a strong background in both clinical care and research. He’s currently the interim director of the Carilion Clinic Aortic Center and interim section chief of Aortic and Endovascular Surgery. In addition to his clinical roles, he’s an assistant professor of Aortic and Endovascular Surgery at Virginia Tech Carilion School of Medicine.
Dr. Dadashzadeh completed his vascular surgery fellowship at Washington University in St. Louis and his general surgery residency at the University of Pittsburgh Medical Center. He also holds a master’s in biomedical informatics from the University of Pittsburgh.
Contact Information
Yili Zhong, Ph.D.
Clinical Research Coordinator
